Notice of updates

We’ve updated our Financial Services Guide (FSG), effective 18 November 2025. By continuing to use our services after this date, you accept the revised terms.

Read FSG

icon
HALO logo
halo search icon
Regeneron Pharmaceuticals, Inc.

US$774.66

Price Change Indicator
2.63 (0.341%)
Regeneron Pharmaceuticals, Inc.
REGN · NAS

Regeneron Pharmaceuticals, Inc.

Start Trading REGN for Free

US$774.66

Price Arrow2.63 (0.341%)
11/03/2026 04:00:00 PM
All-CompaniesAll-ConsensusEngulfing BullishEngulfing Bullish (Realtime)HALO 200HALO 500HALO AllHALO Balance Sheet+3
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Regeneron Pharmaceuticals, Inc. Overview

REGN Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

HALO Model

Mqv

Strong

Garp

Neutral

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Strong

Earnings

Very Strong

Growth

Earnings

Weak

Dividends

Neutral

Quality

Capital Efficiency

Strong

Balance Sheet

Very Strong

About REGN

icon
icon

Telephone

1.914.847.7000

icon

Address

777 Old Saw Mill River Road, Tarrytown, NY 10591-6707

Description

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

REGN Price Chart

Key Stats

Market Cap

US$81.21B

PE

17.20

EV/EBITDA

13.7

Dividends Overview

DIV Yield

0.4%

Franking

N/A

Ex Dividend Date (est.)

20-Feb-26

Market Data

52 weeks range

Low 476.49 - 821.11

Trade Value (12mth)

US$164,740,382.00

1 week

1.6%

1 month

-1.48%

YTD

-0.55%

1 year

11.97%

All time high

1211.20

Key Fundamentals

EPS 3 yr Growth

9.40%

EBITDA Margin

36.20%

Operating Cashflow

$6,651m

Free Cash Flow Return

0.00%

ROIC

0.00%

Interest Coverage

118.40

Quick Ratio

0.00

Other Data

Shares Outstanding (Fully Diluted)

109m

HALO Sector

Healthcare

Next Company Report Date

29-Jan-27

Next Ex Dividend Date

20-Feb-26

Next Dividend Pay Date

05-Mar-26

Reporting Currency

USD

Short Sell (% of issue)

0.00

REGN Announcements

Latest Announcements

DateAnnouncements
05 February 26
05 February 26
05 February 26
30 January 26
30 January 26

REGN Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock37.0540.944.31locklocklock
EPS (Fully Diluted)
 $locklocklocklock34.7738.34N/Alocklocklock
Growth
 %locklocklocklock-8.510.48.3locklocklock
PE
 Xlocklocklocklock22.514.817.2locklocklock
EV/EBITDA
 Xlocklocklocklock18.211.713.7locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

20-Feb-26

DIV Yield

0.4%

Franking Level

N/A

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Want to learn more?Frequently asked questions.
What is the current share price of Regeneron Pharmaceuticals, Inc. (REGN:NAS)?
Halo FAQ
The current share price of Regeneron Pharmaceuticals, Inc. (REGN:NAS) is USD$774.66.
What is the 52-week high share price for Regeneron Pharmaceuticals, Inc. (REGN:NAS)?
Halo FAQ
The 52-week high share price for Regeneron Pharmaceuticals, Inc. (REGN:NAS) is USD$821.11.
What is the 52-week low share price for Regeneron Pharmaceuticals, Inc. (REGN:NAS)?
Halo FAQ
The 52-week low share price for Regeneron Pharmaceuticals, Inc. (REGN:NAS) is USD$476.49.
What is the dividend yield for Regeneron Pharmaceuticals, Inc. (REGN:NAS)?
Halo FAQ
The current TTM dividend payout for Regeneron Pharmaceuticals, Inc. (REGN:NAS) is 0.40.
What was Regeneron Pharmaceuticals, Inc. (REGN:NAS) last dividend payment?
Halo FAQ
The last dividend payment of Regeneron Pharmaceuticals, Inc. (REGN:NAS) is USD$0.94.
What is the franking level for Regeneron Pharmaceuticals, Inc. (REGN:NAS)?
Halo FAQ
Regeneron Pharmaceuticals, Inc. (REGN:NAS) has a franking level of 0.00%.
In which sector is Regeneron Pharmaceuticals, Inc. (REGN:NAS) classified?
Halo FAQ
Regeneron Pharmaceuticals, Inc. (REGN:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Regeneron Pharmaceuticals, Inc. (REGN:NAS)?
Halo FAQ
The current P/E ratio for Regeneron Pharmaceuticals, Inc. (REGN:NAS) is 17.20.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial